[go: up one dir, main page]

Falls, 1998 - Google Patents

The physiological implications of the gamma A/gamma'fibrin (ogen) and factor XIII interaction

Falls, 1998

Document ID
2830903266933519170
Author
Falls L
Publication year

External Links

Snippet

Elevated fibrinogen constitutes a risk factor for thrombosis. Two mechanisms by which fibrinogen may contribute to thrombosis are described. First, fibrinolysis rates decrease inversely with initial fibrinogen concentrations. Second, a minor variant, γA/γ′ fibrinogen …
Continue reading at search.proquest.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)

Similar Documents

Publication Publication Date Title
Muszbek et al. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions
Lagrange et al. Alpha‐2‐macroglobulin in hemostasis and thrombosis: an underestimated old double‐edged sword
Ariëns Fibrin (ogen) and thrombotic disease
Liotta et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane
Bolton‐Maggs et al. The rare coagulation disorders–review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation
Muszbek et al. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function
Wolberg Thrombin generation and fibrin clot structure
Schroeder et al. New developments in the area of factor XIII
Broze Jr Tissue factor pathway inhibitor and the current concept of blood coagulation
Siconolfi et al. Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush
Kalafatis et al. The regulation of clotting factors
Lawson et al. Challenges for providing effective hemostasis in surgery and trauma
Dahlback Factor V and protein S as cofactors to activated protein C
UA68333C2 (en) Modified factor vii
CA2326588A1 (en) Methods for treating an ischemic disorder and improving stroke outcome
Ruggeri The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces
Gui et al. Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV
Murano Plasma protein function in hemostasis
JPH08506181A (en) Novel anticoagulant cofactor activity
Rea et al. Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A
US20050250688A1 (en) Methods for treating an ischemic disorder and improving stroke outcome
Jiewen et al. A missense mutation in lectin domain of thrombomodulin causing functional deficiency
Salomon et al. Inhibitors to factor XI in patients with severe factor XI deficiency
Gentry et al. Human ovarian follicular fluid has functional systems for the generation and modulation of thrombin
Murano A basic outline of blood coagulation